Skip to main content
OpenTrials
Not Yet Recruiting

NCT Number: NCT07194291

Menses&Change in Diabetic Girl

To assess menstraul cycle changes in adolescent girls with diabetes and to find out the various risk factors

Not Yet Recruiting

Trial opening soon.

Get Notified

Key information

About this study

Type 1 diabetes mellitus (T1DM) is the result of autoimmunity mediated destruction of pancreatic beta cells, ultimately causing insulin deficiency and, consequently, hyperglycemia .

Typically the diagnosis of T1DM is made in childhood or adolescence,but about 40% of affected individuals are diagnosed in adulthood.

Hyperglycemia-related complications can contribute to impairment of endocrine axes, such as the hypothalamic pituitary gonadal (HPG) axis .

Historically, before the introduction of insulin replacement therapy, prepubertal girls wh developed T1DM rarely showed normal sexual development, exhibiting primary amenorrhea .

Although the introduction of insulin drastically changed the natural history of T1DM, allowing restoration of the HPG physiology, menarche delay remained as a typical sign in girls with T1DM .

In addition, women with T1DM report a higher incidence of menstrual irregularities >30%

compared with control subjects without diabetes .

Accordingly, signs and symptoms of androgen excess, such as acne and hirsutism, are more frequent in women with T1DM than in their age-matched counterparts

These interconnected abnormalities contribute to the reduced fertility observed in women with T1DM, as characterized by fewer pregnancies and live births and earlier menopause compared with women without diabetes.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Girls with diabetes diagnosed based on ADA guidelines Who reatched menarche of at least 1year duration [14]]
  • Another comparable number of age matched non_diabetic girls will be included as controls.

3/Female adolescents aged 10-18 years

Exclusion criteria

  • Girls Known thyroid disease or other endocrine disorders affecting menstruation
  • Girls taking medications that may affect menstrual cycles like Use of hormonal therapy (e.g., oral contraceptive pills) within the last 6 months
  • Menstraul irregularitis prior to diagnosis of diabetes

Treatment and study plan

Follow up of female sexual function

Other

We follow up menstrual changes in diabetic adolescent girls to improve the outcome

Primary outcomes

  1. Number of participants with menstrual irregularities

    Time frame: 12 months (from enrollment)

    Menstrual cycle characteristics (cycle length, frequency, and regularity) will be documented using a structured menstrual diary and standardized questionnaire. Menstrual irregularity will be defined as the presence of oligomenorrhea (cycle length > 35 days), amenorrhea (≥ 3 months without menstruation), or polymenorrhea (cycle length < 21 days). Data will be summarized as the number and percentage of participants meeting any of these criteria.

Secondary outcomes

  1. Association of menstrual irregularities with HbA1c and BMI

    Time frame: 12 months (from enrollment)

    HbA1c levels and body mass index (BMI) will be recorded at baseline and at 12 months. Data will be analyzed to assess correlations between menstrual irregularities and glycemic control (HbA1c, %) and nutritional status (BMI, kg/m²).

Study contacts

Contact information is provided by the study sponsor or research team.

Zeinab megahed Mohamed, Principal Investigator

CONTACT

[email protected]

+20 10 07907104

Sponsors and collaborators

Lead sponsor

Assiut University

Other

Registry information

Official study title

Menstrual Cycle Changes in Adolescent Girls With Diabetes

Important dates

Study start
2025
Primary completion
2026
Study completion
2026
First posted
Sep 26, 2025
Registry last updated
Sep 26, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.